Denniff Philip, Spooner Neil
Platform Technology & Science, Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research & Development, Ware, Hertfordshire, SG12 0DP, UK.
Bioanalysis. 2010 Aug;2(8):1385-95. doi: 10.4155/bio.10.103.
As hematocrit levels are known to vary between individuals and with disease state, its effect on the physical characteristics of dried blood spot (DBS) samples and on the accurate quantification of analytes within these samples is examined.
The area of DBS samples decreases with increasing hematocrit levels in a linear manner on the three cellulose paper substrates tested. Furthermore, a bias was observed in the concentrations of two analytes determined in DBS samples at different hematocrits, which in some cases exceeded acceptable values, particularly for hematocrits outside normal values.
If it is expected that the hematocrit of study samples will vary from values considered normal, then its effect on the quantitative determination of an analyte in DBS samples should be investigated as part of the method development and validation. If an unacceptable effect is observed, then this will need to be addressed, by modification of the analytical method, or the inclusion of quality control samples at different hematocrit levels to show control of the assay.
由于已知血细胞比容水平在个体之间以及随疾病状态而变化,因此研究了其对干血斑(DBS)样本物理特性以及这些样本中分析物准确定量的影响。
在所测试的三种纤维素纸基质上,DBS样本的面积随着血细胞比容水平的升高呈线性下降。此外,在不同血细胞比容的DBS样本中测定的两种分析物浓度存在偏差,在某些情况下超过了可接受值,特别是对于超出正常值的血细胞比容。
如果预期研究样本的血细胞比容将不同于正常考虑的值,那么作为方法开发和验证的一部分,应研究其对DBS样本中分析物定量测定的影响。如果观察到不可接受的影响,则需要通过修改分析方法或纳入不同血细胞比容水平的质量控制样本以显示分析的可控性来解决此问题。